Vice President, Communications, Public Affairs and Policy Advocacy, Europe at Revolution Medicines

Basel, Basel-City, Switzerland -

Full Time

Start Date

Immediate

Expiry Date

21 Apr, 26

Salary

0.0

Posted On

21 Jan, 26

Experience

10 year(s) or above

Remote Job

Yes

Telecommute

Yes

Sponsor Visa

Skills

Leadership, Influence, Teamwork, Communications, Public Affairs, Policy Advocacy, Stakeholder Engagement, Interpersonal Skills, Verbal Communication, Written Communication, Storytelling, Policy Translation, Oncology Knowledge, Healthcare Policy, Media Relations, Crisis Management, Digital Engagement

Industry

Hospitals and Health Care

Description

Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit frontier targets in RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies. As a new member of the Revolution Medicines team, you will join other outstanding Revolutionaries in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Communications, Public Affairs and Policy Advocacy function plays a central role in shaping healthcare environments to improve outcomes for cancer patients, strengthen healthcare systems, and ensure timely access to innovation. This position will lead the development and execution of oncology-focused Public Affairs and Communication strategies at European levels, integrating policy, patient advocacy, and other stakeholder engagement. The VP will represent the company as a transformative oncology voice across Europe, influencing external policy and communication environments to accelerate access to innovation. Reporting to the SVP Head of Europe with a strong dotted line to the global functional leaders they ensure that the oncology public affairs strategy is aligned with regional business priorities and the rapidly evolving European policy landscape. It enables close collaboration with country teams, strong alignment with European institutions and policymakers, and effective engagement with cancer patient organizations and coalitions across Europe. Policy and Stakeholder Environment Map and assess the evolving oncology policy environment, particularly within Europe (institutions, national governments, payers, HTA bodies). Monitor EU legislative processes (e.g., Pharma Legislation reform, HTA Regulation implementation, Cancer Mission) and help assess impact on business. Identify key opportunities and risks to shape cancer care policy, access, and innovation. Act as the primary point of contact for European health policy stakeholders, ensuring the company has a consistent and influential presence. Develop company positions and help affiliates represent the company in trade and industry associations. Design and implement comprehensive Communications, Public Affairs and Policy Advocacy strategies for the oncology portfolio, ensuring integration with brand, access, and corporate strategies. Lead engagement with European institutions (European Commission, European Parliament, EMA, ECDC) on cancer-related policy and regulatory issues. External Thought Leadership and Media Relations Thought Leadership Development: Position the company as a credible oncology innovator by shaping narratives on cancer policy, access, and innovation in European media and policy forums. Develop senior executive visibility strategies (speaking engagements, op-eds, conference participation) aligned with corporate and scientific priorities. Media Engagement & Reputation Management: Build and maintain trusted relationships with top-tier European and trade media, ensuring accurate representation of company positions and achievements. Oversee proactive and reactive media communications, including issue and crisis management, to protect and enhance the company’s reputation. Internal Communication Strategic Message Integration: Ensure internal messaging reflects external priorities, aligning employees around the company’s mission, oncology strategy, and advocacy efforts. Collaborate with leadership to cascade key European policy and access milestones through engaging internal channels. Employee Engagement & Change Communication: Partner with HR and corporate functions to drive a strong internal culture of transparency, inclusion, and purpose. Develop internal campaigns that celebrate wins and strengthen organizational pride in the company’s oncology impact. Capability and Capacity Building Partner with country teams across Europe to ensure consistent execution of Communications, Public Affairs and Policy Advocacy strategies at the national level. Develop best practice toolkits, guidance, and training to build advocacy and policy capacity locally. Develop digital and media engagement which are increasingly core to advocacy and public affairs. Foster cross-country learning and ensure alignment on key oncology policy initiatives. Foster a culture of transparent and ethical stakeholder collaboration across markets. Cross-Functional Leadership Serve as a core member of global and regional oncology brand teams, asset leadership teams, and launch taskforces. Partner with Global Communications to ensure alignment of European external messaging with corporate narrative and media relations. Provide senior counsel on Public Affairs & Communications & Advocacy matters, and its stakeholder engagements to business leaders. Support corporate reputation management and thought leadership initiatives in oncology under the direction of the Global Communications function. Regional–Global Communications Alignment Partner with the Global Head of Communications to ensure European communications reinforce the global corporate narrative, values, and scientific leadership priorities. Provide European policy insights, advocacy trends, and oncology milestones to shape and enrich the global corporate narrative with relevant, authentic regional examples. Ensure disciplined, consistent messaging across earned, owned, and shared channels in Europe, in coordination with global communications teams. Work jointly with Global Communications and Corporate Affairs to anticipate, prepare for, and manage issues or crises affecting the company’s reputation, products, or leadership. Coordinate with global teams to support European executive visibility and representation at international oncology, policy, and innovation platforms. Collaborate with global media relations on spokesperson strategy, region-specific narratives, and media plans that reinforce global priorities. Partner with global communications to ensure internal communications in Europe align with global tone, cadence, and key messages, supporting a unified, engaged workforce. Required Skills, Experience and Education: Degree in Law, Communications, Political Science, Public Health, Life Sciences, or related fields. Excellent leadership, influence, and teamwork mindset. Strong ability to develop and deliver impactful Communications, Public Affairs and Policy Advocacy campaigns. Excellent interpersonal, verbal, and written communication skills, including storytelling and policy translation for lay audiences. Skilled in managing complex stakeholder environments and partnerships. Minimum 15 years in Communications, Public Affairs and Policy Advocacy, preferably in oncology or rare diseases. Deep understanding of the European healthcare policy and oncology landscape, with strong networks across institutions, cancer alliances, and advocacy groups. Proven track record of engaging with patient organizations, industry associations, and policymakers to deliver tangible policy and access outcomes. Experience in launching new oncology medicines and shaping policy to enable faster patient access. Familiarity with reimbursement, HTA processes, and access barriers in oncology. Strong track record of managing teams across multiple European countries. Preferred Skills: Fluent in English, other languages are considered advantageous Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact privacy@revmed.com. #LI-Remote #LI-LO1

Responsibilities

The VP will lead the development and execution of oncology-focused Public Affairs and Communication strategies at European levels, influencing external policy and communication environments. They will also engage with European institutions on cancer-related policy and regulatory issues.